864 related articles for article (PubMed ID: 11462772)
1. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
[TBL] [Abstract][Full Text] [Related]
2. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
Reiter RJ; Tan DX; Manchester LC; Qi W
Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
[TBL] [Abstract][Full Text] [Related]
3. Suppression of oxygen toxicity by melatonin.
Reiter RJ; Tan DX; Qi WB
Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
[TBL] [Abstract][Full Text] [Related]
4. Melatonin in relation to cellular antioxidative defense mechanisms.
Reiter RJ; Carneiro RC; Oh CS
Horm Metab Res; 1997 Aug; 29(8):363-72. PubMed ID: 9288572
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
Reiter RJ; Tan DX; Gitto E; Sainz RM; Mayo JC; Leon J; Manchester LC; Vijayalaxmi ; Kilic E; Kilic U
Pol J Pharmacol; 2004; 56(2):159-70. PubMed ID: 15156066
[TBL] [Abstract][Full Text] [Related]
6. [Free oxygen radiacals and kidney diseases--part I].
Sakac V; Sakac M
Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
[TBL] [Abstract][Full Text] [Related]
7. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
Reiter RJ
Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
[TBL] [Abstract][Full Text] [Related]
8. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.
Reiter RJ; Tan DX; Mayo JC; Sainz RM; Leon J; Czarnocki Z
Acta Biochim Pol; 2003; 50(4):1129-46. PubMed ID: 14740000
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective role of melatonin in oxidative stress vulnerable brain.
Gupta YK; Gupta M; Kohli K
Indian J Physiol Pharmacol; 2003 Oct; 47(4):373-86. PubMed ID: 15266948
[TBL] [Abstract][Full Text] [Related]
10. An epigrammatic (abridged) recounting of the myriad tales of astonishing deeds and dire consequences pertaining to nitric oxide and reactive oxygen species in mitochondria with an ancillary missive concerning the origins of apoptosis.
Heck DE; Kagan VE; Shvedova AA; Laskin JD
Toxicology; 2005 Mar; 208(2):259-71. PubMed ID: 15691590
[TBL] [Abstract][Full Text] [Related]
11. Actions of melatonin in the reduction of oxidative stress. A review.
Reiter RJ; Tan DX; Osuna C; Gitto E
J Biomed Sci; 2000; 7(6):444-58. PubMed ID: 11060493
[TBL] [Abstract][Full Text] [Related]
12. Oxidative toxicity in models of neurodegeneration: responses to melatonin.
Reiter RJ; Garcia JJ; Pie J
Restor Neurol Neurosci; 1998 Jun; 12(2-3):135-42. PubMed ID: 12671308
[TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection.
Guha M; Maity P; Choubey V; Mitra K; Reiter RJ; Bandyopadhyay U
J Pineal Res; 2007 Nov; 43(4):372-81. PubMed ID: 17910606
[TBL] [Abstract][Full Text] [Related]
14. The oxidant/antioxidant network: role of melatonin.
Reiter RJ; Tan DX; Cabrera J; D'Arpa D; Sainz RM; Mayo JC; Ramos S
Biol Signals Recept; 1999; 8(1-2):56-63. PubMed ID: 10085463
[TBL] [Abstract][Full Text] [Related]
15. Total antioxidant capacity and nuclear DNA damage in keratinocytes after exposure to H2O2.
Armeni T; Battino M; Stronati A; Pugnaloni A; Tomassini G; Rosi G; Biagini G; Principato G
Biol Chem; 2001 Dec; 382(12):1697-705. PubMed ID: 11843183
[TBL] [Abstract][Full Text] [Related]
16. [Free radicals and antioxidants: human physiology, pathology and therapeutic aspects].
Sahnoun Z; Jamoussi K; Zeghal KM
Therapie; 1997; 52(4):251-70. PubMed ID: 9437876
[TBL] [Abstract][Full Text] [Related]
17. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
18. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites.
Reiter RJ; Tan DX; Jou MJ; Korkmaz A; Manchester LC; Paredes SD
Neuro Endocrinol Lett; 2008 Aug; 29(4):391-8. PubMed ID: 18766165
[TBL] [Abstract][Full Text] [Related]
19. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.
Reiter RJ; Tan DX; Allegra M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343
[TBL] [Abstract][Full Text] [Related]
20. Melatonin oxidative stress and neurodegenerative diseases.
Srinivasan V
Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
